Dokha

Introduction

Dokha is a traditional Arabian tobacco product known for its unique blend of dried and finely shredded tobacco flakes combined with various herbs and spices. This distinctive tobacco has roots tracing back to the 15th century in Iran.

Dokha tobacco used in midwakh pipe.

Dokha tobacco fillesd in a midwakh pipe.

History

Origin

Dokha originated in Iran during the 15th century. Its creation marked a notable development in the tobacco industry of the region, setting it apart from other contemporary tobacco products.

Characteristics

Composition

Unlike many other tobacco products like the hookah tobacco (shisha or mu'assel), dokha does not undergo curing with molasses. This results in a more potent and traditional tobacco flavor. Its unique taste and aroma are attributed to the inclusion of various herbs and spices in the blend.

Consumption

Dokha is typically smoked in small amounts due to its strength. This is facilitated by a special pipe known as a midwakh. The close association between the midwakh pipe and dokha has led to the terms being frequently used interchangeably.

Cultural Significance

Dokha has deeply ingrained itself into the Arabian culture over the centuries. Its unique preparation and consumption method using the midwakh pipe, combined with the rich history, have solidified its status as a significant cultural product in the Middle East.

Comparison with Other Tobacco Products

While dokha and hookah tobacco are both popular in the Middle East, they differ substantially. Dokha's raw and potent nature, devoid of molasses curing, contrasts sharply with the sweetened and often fruit-flavored experience of hookah tobacco.

Conclusion

Dokha offers a potent and traditional tobacco experience that has been cherished in the Middle East for centuries. Its rich history and unique consumption method using the midwakh pipe make it a distinctive aspect of Arabian culture.

Dokha Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.